Non-Hodgkin's Lymphoma is a cancer that starts in the lymph system but does not involve the specific cells that define Hodgkin lymphoma

Non-Hodgkin's lymphoma (NHL) is a group of blood cancers that develop in the lymphocytes — the white blood cells that fight infection. The key difference from Hodgkin lymphoma is the absence of Reed-Sternberg cells, a specific abnormal cell type that pathologists look for under a microscope. If those cells are present, the diagnosis is Hodgkin lymphoma. If they are not, it is Non-Hodgkin's lymphoma, even if the cancer started in the same lymph nodes.

NHL is actually many different diseases grouped under one name because they all behave differently, grow at different speeds, and respond to different treatments. Some types are slow-growing and may not need immediate treatment. Others are aggressive and require urgent care. The specific type matters far more than the NHL label itself, which is why your pathology report will name the exact subtype — diffuse large B-cell lymphoma, follicular lymphoma, Burkitt lymphoma, or one of dozens of others.

Key Takeaways

  • Non-Hodgkin's lymphoma is defined by the absence of Reed-Sternberg cells under the microscope, not by where the cancer started.
  • NHL includes many subtypes that behave very differently — some slow-growing and some aggressive — so the specific type determines treatment and outlook.
  • About 80 percent of NHL cases are B-cell lymphomas, which start in B lymphocytes, while the remaining 20 percent are T-cell lymphomas.
  • Symptoms can include swollen lymph nodes, fever, night sweats, and weight loss, but many people have no symptoms when diagnosed.
  • Staging and the specific subtype are what drive treatment decisions, not the NHL diagnosis alone.

How Non-Hodgkin's Lymphoma Develops in the Lymph System

The lymph system includes lymph nodes, the spleen, bone marrow, and thymus gland. Lymphocytes normally grow and divide in an orderly way, then die when they are no longer needed. In NHL, a mutation causes one lymphocyte to divide repeatedly without stopping, creating a clone of identical abnormal cells. These cells crowd out healthy lymphocytes and accumulate in lymph nodes, the spleen, bone marrow, or other organs.

The mutation that starts NHL is not inherited — it happens by chance in one cell during a person's lifetime. This is why NHL is not passed down from parent to child. The exact cause of the mutation is usually unknown, though certain infections (like HIV or hepatitis C), autoimmune diseases, and some medications can increase the risk. Most people who develop NHL have no known risk factor.

Because NHL can start anywhere in the lymph system, it can appear in lymph nodes in the neck, chest, abdomen, or groin, or it can start in the spleen, bone marrow, liver, or even the brain or digestive tract. This is different from some cancers that start in one organ and spread. NHL often involves multiple sites from the beginning.

B-Cell and T-Cell Lymphomas: The Two Main Categories

All NHL subtypes fall into two broad groups based on which type of lymphocyte is affected. B-cell lymphomas make up about 80 percent of cases and start in B lymphocytes, which normally produce antibodies. T-cell lymphomas make up about 20 percent and start in T lymphocytes, which normally coordinate immune response and kill infected cells.

B-cell lymphomas include common subtypes like follicular lymphoma (slow-growing), diffuse large B-cell lymphoma (aggressive), and Burkitt lymphoma (very aggressive). T-cell lymphomas include peripheral T-cell lymphoma and cutaneous T-cell lymphoma, which can affect the skin. The behavior and treatment of B-cell and T-cell lymphomas are often quite different, so knowing which one you have is essential information for your doctor.

Within each category, subtypes are further divided by how fast they grow. Indolent (slow-growing) lymphomas may not cause symptoms for years and sometimes do not need treatment right away. Aggressive lymphomas grow quickly, cause symptoms sooner, and usually require prompt treatment. Some lymphomas can transform from slow-growing to aggressive over time.

Common Symptoms and How They Are Detected

Many people with NHL have no symptoms when the cancer is found — it may be discovered by chance on imaging done for another reason, or during a routine blood test. When symptoms do occur, they often include swollen lymph nodes in the neck, underarm, or groin that do not go away after a few weeks. The swollen nodes are usually painless, though some people report pain after drinking alcohol.

Other symptoms can include fever, night sweats that soak through clothing, unexplained weight loss, fatigue, and shortness of breath. These are sometimes called B symptoms because they are tracked separately in staging. The presence or absence of B symptoms affects how doctors stage the cancer and sometimes influences treatment decisions.

NHL is diagnosed through a lymph node biopsy, in which a sample of tissue is removed and examined under a microscope. A biopsy is the only way to confirm NHL and identify the specific subtype. Blood tests, CT scans, and PET scans help determine how far the cancer has spread, but they cannot diagnose NHL on their own.

Staging: How Doctors Measure How Far the Cancer Has Spread

Staging tells you which lymph nodes and organs are involved and helps your doctor plan treatment. NHL uses the Lugano classification, which divides cases into four stages. Stage I means cancer is in one lymph node region or one organ. Stage II means cancer is in two or more node regions on the same side of the diaphragm (the muscle that separates the chest from the abdomen). Stage III means cancer is on both sides of the diaphragm. Stage IV means cancer is in the bone marrow, liver, central nervous system, or other organs outside the lymph system.

Staging requires imaging — usually a CT scan of the chest, abdomen, and pelvis, and sometimes a PET scan. A bone marrow biopsy may be done to check for involvement there. Your doctor may also order blood tests to measure kidney and liver function, which affects what treatments are safe for you.

The stage combined with the subtype and your age and overall health determine what treatment is recommended. Two people with the same stage can receive very different treatment plans if their subtypes are different or if one person has other health conditions that limit what drugs can be used.

Treatment Approaches Vary Widely by Subtype and Stage

Treatment for NHL is not one-size-fits-all. Slow-growing lymphomas in early stages may be watched without treatment — a strategy called watch and wait — because starting treatment does not improve survival and exposes you to side effects unnecessarily. If the cancer grows or causes symptoms, treatment begins then.

When treatment is needed, options include chemotherapy, targeted therapy (drugs that attack specific features of the cancer cells), immunotherapy (drugs that help your immune system fight the cancer), and radiation. Many people receive a combination of these. For some aggressive subtypes, high-dose chemotherapy followed by stem cell transplant may be recommended. For others, a single targeted drug may be enough.

Your treatment plan depends on the specific subtype, stage, whether you have B symptoms, your age, and whether you have other health conditions. This is why two people both diagnosed with NHL may have completely different treatment paths. Your oncologist will discuss the options, the expected side effects, and the goal of treatment — whether it is to cure the cancer, control it long-term, or manage symptoms.

Prognosis and Survival Rates

Prognosis for NHL varies enormously by subtype. Some slow-growing lymphomas have very long survival times — people may live 10, 15, or 20 years or more after diagnosis, even with periods of treatment and watch-and-wait. Some aggressive lymphomas, if caught early and treated aggressively, have high cure rates. Others have lower cure rates but can still be controlled for years.

Survival also depends on factors beyond the subtype: your age, whether you have B symptoms, how high your lactate dehydrogenase (LDH) level is, and how many lymph node regions are involved. Doctors use these factors to calculate a prognostic index that predicts how the cancer is likely to behave. This is not a may provide — it is a statistical average — but it helps your doctor explain what to expect and why certain treatments are recommended.

Advances in treatment over the past 10 to 15 years have improved outcomes for many NHL subtypes. Newer targeted drugs and immunotherapies have changed what was once a poor prognosis into a manageable long-term condition for some people. Your doctor can discuss the specific outlook for your subtype and stage.

Frequently Asked Questions

Is Non-Hodgkin's lymphoma hereditary?

No. The mutation that causes NHL happens by chance in one cell during your lifetime and is not passed down from parents to children. You cannot inherit NHL, and you cannot pass it to your children. Having a family member with NHL does not increase your risk.

Can Non-Hodgkin's lymphoma turn into Hodgkin lymphoma?

No. The two are separate diseases defined by different cell types under the microscope. NHL does not transform into Hodgkin lymphoma. However, some NHL subtypes can transform into a more aggressive form of NHL — for example, follicular lymphoma can transform into diffuse large B-cell lymphoma.

What does watch and wait mean?

Watch and wait means your doctor monitors the cancer with regular blood tests and imaging but does not start treatment right away. This approach is used for slow-growing lymphomas in early stages because starting treatment does not improve survival and exposes you to side effects. Treatment begins if the cancer grows or causes symptoms.

Does Non-Hodgkin's lymphoma always require chemotherapy?

No. Treatment depends on the subtype, stage, and your overall health. Some slow-growing lymphomas may never need treatment. Others respond to targeted drugs or immunotherapy alone. Chemotherapy is one option among many, and your doctor will discuss which treatments are recommended for your specific situation.

Can you survive Non-Hodgkin's lymphoma?

Yes. Survival depends heavily on the subtype and stage. Some slow-growing lymphomas are managed as long-term conditions with good quality of life. Some aggressive lymphomas, especially when caught early, have high cure rates. Your doctor can discuss the specific outlook for your subtype based on current treatment options.